MedTrace Logo

Tack Optimized Balloon Angioplasty Post-Market Study

NCT05361967 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2024-08-09

No results posted yet for this study

Summary

The objective of this study is to obtain outcomes following dissection repair with the Tack Endovascular System in a broad population of patients undergoing endovascular treatment of lesions within the superficial femoral, popliteal, peroneal, and/or tibial arteries.

Conditions

  • PAD - Peripheral Arterial Disease
  • PAD
  • Dissection
  • Arterial Dissection
  • Peripheral Arterial Disease
  • Peripheral Vascular Diseases

Interventions

DEVICE

The Tack Endovascular System

The Tack Endovascular System is designed to treat vascular dissections with Tack implant(s) following angioplasty.

Sponsors & Collaborators

  • Spectranetics Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-30
Primary Completion
2024-06-01
Completion
2024-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05361967 on ClinicalTrials.gov